Bayer stock continues rout after $2 bln award in Roundup trial

Shares in Bayer fell as much as 5 percent on Tuesday after a jury awarded more than $2 billion to a California couple in the largest U.S. jury verdict against the company over allegations its Roundup weed killer causes cancer. Pascale Davies reports.

Multimedia

Most Popular Videos